CC vs REGN · P/E 72, rev $1.36B vs P/E 14, rev $14.34B
Chemours Co (CC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CC currently screens at market cap $1.94B and trailing P/E 71.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CC and REGN stock pages for the full models.
Not investment advice.